Cargando…
Enhanced microbubble contrast agent oscillation following 250 kHz insonation
Microbubble contrast agents are widely used in ultrasound imaging and therapy, typically with transmission center frequencies in the MHz range. Currently, an ultrasound center frequency near 250 kHz is proposed for clinical trials in which ultrasound combined with microbubble contrast agents is appl...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218550/ https://www.ncbi.nlm.nih.gov/pubmed/30397280 http://dx.doi.org/10.1038/s41598-018-34494-5 |
_version_ | 1783368478169759744 |
---|---|
author | Ilovitsh, Tali Ilovitsh, Asaf Foiret, Josquin Caskey, Charles F. Kusunose, Jiro Fite, Brett Z. Zhang, Hua Mahakian, Lisa M. Tam, Sarah Butts-Pauly, Kim Qin, Shengping Ferrara, Katherine W. |
author_facet | Ilovitsh, Tali Ilovitsh, Asaf Foiret, Josquin Caskey, Charles F. Kusunose, Jiro Fite, Brett Z. Zhang, Hua Mahakian, Lisa M. Tam, Sarah Butts-Pauly, Kim Qin, Shengping Ferrara, Katherine W. |
author_sort | Ilovitsh, Tali |
collection | PubMed |
description | Microbubble contrast agents are widely used in ultrasound imaging and therapy, typically with transmission center frequencies in the MHz range. Currently, an ultrasound center frequency near 250 kHz is proposed for clinical trials in which ultrasound combined with microbubble contrast agents is applied to open the blood brain barrier, since at this low frequency focusing through the human skull to a predetermined location can be performed with reduced distortion and attenuation compared to higher frequencies. However, the microbubble vibrational response has not yet been carefully evaluated at this low frequency (an order of magnitude below the resonance frequency of these contrast agents). In the past, it was assumed that encapsulated microbubble expansion is maximized near the resonance frequency and monotonically decreases with decreasing frequency. Our results indicated that microbubble expansion was enhanced for 250 kHz transmission as compared with the 1 MHz center frequency. Following 250 kHz insonation, microbubble expansion increased nonlinearly with increasing ultrasonic pressure, and was accurately predicted by either the modified Rayleigh–Plesset equation for a clean bubble or the Marmottant model of a lipid-shelled microbubble. The expansion ratio reached 30-fold with 250 kHz at a peak negative pressure of 400 kPa, as compared to a measured expansion ratio of 1.6 fold for 1 MHz transmission at a similar peak negative pressure. Further, the range of peak negative pressure yielding stable cavitation in vitro was narrow (~100 kPa) for the 250 kHz transmission frequency. Blood brain barrier opening using in vivo transcranial ultrasound in mice followed the same trend as the in vitro experiments, and the pressure range for safe and effective treatment was 75–150 kPa. For pressures above 150 kPa, inertial cavitation and hemorrhage occurred. Therefore, we conclude that (1) at this low frequency, and for the large oscillations, lipid-shelled microbubbles can be approximately modeled as clean gas microbubbles and (2) the development of safe and successful protocols for therapeutic delivery to the brain utilizing 250 kHz or a similar center frequency requires consideration of the narrow pressure window between stable and inertial cavitation. |
format | Online Article Text |
id | pubmed-6218550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62185502018-11-07 Enhanced microbubble contrast agent oscillation following 250 kHz insonation Ilovitsh, Tali Ilovitsh, Asaf Foiret, Josquin Caskey, Charles F. Kusunose, Jiro Fite, Brett Z. Zhang, Hua Mahakian, Lisa M. Tam, Sarah Butts-Pauly, Kim Qin, Shengping Ferrara, Katherine W. Sci Rep Article Microbubble contrast agents are widely used in ultrasound imaging and therapy, typically with transmission center frequencies in the MHz range. Currently, an ultrasound center frequency near 250 kHz is proposed for clinical trials in which ultrasound combined with microbubble contrast agents is applied to open the blood brain barrier, since at this low frequency focusing through the human skull to a predetermined location can be performed with reduced distortion and attenuation compared to higher frequencies. However, the microbubble vibrational response has not yet been carefully evaluated at this low frequency (an order of magnitude below the resonance frequency of these contrast agents). In the past, it was assumed that encapsulated microbubble expansion is maximized near the resonance frequency and monotonically decreases with decreasing frequency. Our results indicated that microbubble expansion was enhanced for 250 kHz transmission as compared with the 1 MHz center frequency. Following 250 kHz insonation, microbubble expansion increased nonlinearly with increasing ultrasonic pressure, and was accurately predicted by either the modified Rayleigh–Plesset equation for a clean bubble or the Marmottant model of a lipid-shelled microbubble. The expansion ratio reached 30-fold with 250 kHz at a peak negative pressure of 400 kPa, as compared to a measured expansion ratio of 1.6 fold for 1 MHz transmission at a similar peak negative pressure. Further, the range of peak negative pressure yielding stable cavitation in vitro was narrow (~100 kPa) for the 250 kHz transmission frequency. Blood brain barrier opening using in vivo transcranial ultrasound in mice followed the same trend as the in vitro experiments, and the pressure range for safe and effective treatment was 75–150 kPa. For pressures above 150 kPa, inertial cavitation and hemorrhage occurred. Therefore, we conclude that (1) at this low frequency, and for the large oscillations, lipid-shelled microbubbles can be approximately modeled as clean gas microbubbles and (2) the development of safe and successful protocols for therapeutic delivery to the brain utilizing 250 kHz or a similar center frequency requires consideration of the narrow pressure window between stable and inertial cavitation. Nature Publishing Group UK 2018-11-05 /pmc/articles/PMC6218550/ /pubmed/30397280 http://dx.doi.org/10.1038/s41598-018-34494-5 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Ilovitsh, Tali Ilovitsh, Asaf Foiret, Josquin Caskey, Charles F. Kusunose, Jiro Fite, Brett Z. Zhang, Hua Mahakian, Lisa M. Tam, Sarah Butts-Pauly, Kim Qin, Shengping Ferrara, Katherine W. Enhanced microbubble contrast agent oscillation following 250 kHz insonation |
title | Enhanced microbubble contrast agent oscillation following 250 kHz insonation |
title_full | Enhanced microbubble contrast agent oscillation following 250 kHz insonation |
title_fullStr | Enhanced microbubble contrast agent oscillation following 250 kHz insonation |
title_full_unstemmed | Enhanced microbubble contrast agent oscillation following 250 kHz insonation |
title_short | Enhanced microbubble contrast agent oscillation following 250 kHz insonation |
title_sort | enhanced microbubble contrast agent oscillation following 250 khz insonation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218550/ https://www.ncbi.nlm.nih.gov/pubmed/30397280 http://dx.doi.org/10.1038/s41598-018-34494-5 |
work_keys_str_mv | AT ilovitshtali enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT ilovitshasaf enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT foiretjosquin enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT caskeycharlesf enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT kusunosejiro enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT fitebrettz enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT zhanghua enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT mahakianlisam enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT tamsarah enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT buttspaulykim enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT qinshengping enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation AT ferrarakatherinew enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation |